These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16463553)

  • 61. EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
    Palacios S; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
    Maturitas; 2012 Feb; 71(2):194-8. PubMed ID: 22176952
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ask the doctor. I've had osteoporosis for several years, and I've been taking alendronate (Fosamax) once a week. I wasn't very good at remembering to take it regularly, so my doctor recently recommended that I start on once-a-year infusions of zoledronic acid (Reclast). Will it work as well to prevent me from breaking a bone?
    Fabiny A
    Harv Womens Health Watch; 2014 Apr; 21(8):2. PubMed ID: 25097938
    [No Abstract]   [Full Text] [Related]  

  • 63. Bisphosphonates and glucocorticoids: effects on bone quality.
    Lems WF
    Arthritis Rheum; 2007 Nov; 56(11):3518-22. PubMed ID: 17968935
    [No Abstract]   [Full Text] [Related]  

  • 64. Ibandronate (boniva) offers new options for osteoporosis.
    Kessenich CR
    Nurse Pract; 2006 Oct; 31(10):64-6. PubMed ID: 17028500
    [No Abstract]   [Full Text] [Related]  

  • 65. Acute phase reaction with intravenous ibandronate.
    Fit KE; Burkiewicz JS; Griffin BL; Meyer CM
    Am J Med; 2008 Sep; 121(9):e7. PubMed ID: 18724955
    [No Abstract]   [Full Text] [Related]  

  • 66. [Hormone replacement therapy in the management of postmenopausal osteoporosis and prevention of fracture risk].
    Ribot C; Trémollières F
    Presse Med; 2006 Oct; 35(10 Pt 2):1557-63. PubMed ID: 17028521
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bisphosphonates for osteoporosis.
    Vis M; Dijkmans BA; Lems WF
    N Engl J Med; 2011 Feb; 364(6):582-3; author reply 583-4. PubMed ID: 21306267
    [No Abstract]   [Full Text] [Related]  

  • 68. [Postmenopausal osteoporosis].
    Krankenpfl J; 2005; 43(4-6):150. PubMed ID: 16171093
    [No Abstract]   [Full Text] [Related]  

  • 69. Bisphosphonates for osteoporosis.
    Towner S; Burton DS
    N Engl J Med; 2011 Feb; 364(6):583; author reply 583-4. PubMed ID: 21306266
    [No Abstract]   [Full Text] [Related]  

  • 70. Preventing fractures in postmenopausal women: how to assess risk.
    Fung V; Kendler D
    CMAJ; 2011 Dec; 183(18):2129-31. PubMed ID: 22042993
    [No Abstract]   [Full Text] [Related]  

  • 71. Bisphosphonates for Postmenopausal Osteoporosis.
    Ensrud KE
    JAMA; 2021 Jan; 325(1):96. PubMed ID: 33399841
    [No Abstract]   [Full Text] [Related]  

  • 72. [Ibandronate].
    Yamada T; Suzuki M; Kuwahara T; Tanaka Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():536-9. PubMed ID: 15035186
    [No Abstract]   [Full Text] [Related]  

  • 73. Once-monthly oral ibandronate treatment in an adolescent with recurrent fractures and inadequately low bone mass.
    Kutilek S; Plasilová I; Nemec V
    J Paediatr Child Health; 2012 Jul; 48(7):622-3. PubMed ID: 22758903
    [No Abstract]   [Full Text] [Related]  

  • 74. Bone health medications: research questions versus clinical choices.
    Goldstein SR
    Menopause; 2011 Aug; 18(8):835-6. PubMed ID: 21785375
    [No Abstract]   [Full Text] [Related]  

  • 75. Placebo-controlled trials in osteoporosis--proceeding with caution.
    Rosen CJ; Khosla S
    N Engl J Med; 2010 Sep; 363(14):1365-7; discussion e22. PubMed ID: 20879887
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bridging the gap between evidence and practice in osteoporosis.
    Hansen LB
    Am J Health Syst Pharm; 2008 Feb; 65(4):297. PubMed ID: 18238766
    [No Abstract]   [Full Text] [Related]  

  • 77. Bisphosphonates and colon cancer.
    Lankarani KB
    Osteoporos Int; 2013 Mar; 24(3):1139-40. PubMed ID: 22810919
    [No Abstract]   [Full Text] [Related]  

  • 78. Bisphosphonates and colon cancer: reply.
    Pazianas M; Abrahamsen B; Eiken PA; Eastell R; Russell RG
    Osteoporos Int; 2013 Mar; 24(3):1141-2. PubMed ID: 22847317
    [No Abstract]   [Full Text] [Related]  

  • 79. Bone diseases: bisphosphonates in osteoporosis--beyond 5 years.
    Papapoulos SE
    Nat Rev Rheumatol; 2013 May; 9(5):263-4. PubMed ID: 23591488
    [No Abstract]   [Full Text] [Related]  

  • 80. Did prescription bias affect outcomes in a study of the relative effectiveness of osteoporosis drugs?
    Beri A; Khattri S
    Ann Intern Med; 2008 Oct; 149(7):514; author reply 514. PubMed ID: 18838735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.